Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
The purpose of this study is to determine whether Amifostine provides additional protection of salivary gland function over that achieved with IMRT alone.
Head and Neck Cancer
DRUG: Ethyol (drug)
Salivary function at 6 months and yearly compared to pre-treatment salivary function
Local and regional tumor control
The purpose of this study is to determine whether Amifostine provides additional protection of salivary gland function over that achieved with IMRT alone.